Search your stocks

Share

Profile

AJANTPHARMAjanta Pharma Ltd.

2545.8(-0.10%)

1W: -0.50%

1M: -3.32%

1Y: +13.84%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Revenue growth of 15.4% YoY in the latest quarter indicates strong demand.
Profit margins improved to 20.44%, suggesting better cost management.
Operating profit increased significantly by 20.8% in the latest quarter.

NEGATIVES

Expense growth of 12.6% in the last quarter outpaced revenue growth.
Net profit declined by 8.9% compared to the previous quarter.
Other income dropped significantly, impacting overall profitability.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		1,028.44	1,105.15	1,054.08	1,144.92	1,186.64	1,146.13	1,170.41	1,302.65
Expenses		773.83	827.83	811.54	849.27	915.88	869.18	919.11	997.85
Operating Profit		254.61	277.32	242.54	295.65	270.76	276.95	251.30	304.80
Other Income		21.33	13.59	35.50	26.47	19.48	30.44	18.11	26.33
Interest		2.34	2.49	1.53	0.73	6.02	7.91	6.07	5.26
Depreciation		33.71	34.26	34.25	33.97	34.39	35.97	39.78	41.29
Profit Before Tax		275.94	290.91	278.04	322.12	290.24	307.39	269.41	331.13
Tax		80.64	80.88	75.32	76.35	73.76	74.51	44.15	75.79
Net Profit		195.30	210.03	202.72	245.77	216.48	232.88	225.26	255.34
Eps in Rs		15.51	16.68	16.10	19.54	17.27	18.60	18	20.44